HYDREIGHT TECHNOLOGIES INC (NURS.CA) Forecast, Price Target & Analyst Ratings
TSX-V:NURS • CA44877L1013
2.77 CAD
-0.05 (-1.77%)
Last: Mar 4, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HYDREIGHT TECHNOLOGIES INC (NURS.CA).
Forecast Snapshot
Consensus Price Target
CA$9.95
+ 259.03% Upside
Next Earnings Forecast
Release DateApr 29, 2026
PeriodQ4 / 2025
EPS EstimateCA$0.02
Revenue Estimate15.085M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$9.95
Upside
+ 259.03%
From current price of CA$2.77 to mean target of CA$9.95, Based on 6 analyst forecasts
Low
CA$9.60
Median
CA$9.95
High
CA$10.50
Price Target Revisions
1 Month
14.71%
3 Months
14.71%
Price Target Summary
6 analysts have analysed NURS.CA and the average price target is 9.95 CAD. This implies a price increase of 259.03% is expected in the next year compared to the current price of 2.77.
The average price target has been revised upward by 14.71% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
NURS.CA was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NURS.CA.
In the previous month the buy percentage consensus was at a similar level.
NURS.CA was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-27 | Beacon Securities | Maintains | Buy -> Buy |
| 2025-09-15 | Maxim Group | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 29, 2026
PeriodQ4 / 2025
EPS EstimateCA$0.02
Revenue Estimate15.085M
Revenue Q2Q273.34%
EPS Q2QN/A
Number of Analysts2
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-37.38%
EPS (1 Month)
0.00%
EPS (3 Months)
-66.67%
Next Earnings Summary
NURS.CA is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 0.02 CAD and the consensus revenue estimate is 15.09M CAD.
The next earnings revenue estimate has been revised downward by 37.38% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.27M 255.83% | 11.51M 169.54% | 16.045M 39.40% | 36.149M 125.30% | 151.37M 318.74% | 196.02M 29.50% | |
| EBITDA YoY % growth | -1.84M -253.85% | -1.826M 0.78% | -260.1K 85.75% | 2.075M 897.77% | 15.161M 630.65% | 35.42M 133.63% | |
| EBIT YoY % growth | -1.88M -261.54% | -1.934M -2.87% | -441.2K 77.19% | 1.588M 459.93% | 22.724M 1,330.98% | 38.162M 67.94% | |
| Operating Margin | -44.03% | -16.80% | -2.75% | 4.39% | 15.01% | 19.47% | |
| EPS YoY % growth | N/A | N/A | N/A | 0.04 | 0.28 600.00% | 0.55 92.86% |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.02 | 0.05 | 0.06 | 0.07 607.00% | 0.10 400.00% | 0.11 120.00% | 0.13 116.67% | 0.14 100.00% | 0.16 60.00% |
| Revenue Q2Q % growth | 15.085M 273.34% | 27.875M 513.97% | 30.886M 320.27% | 33.455M 218.01% | 39.124M 159.36% | 42.712M 53.23% | 46.282M 49.85% | 49.135M 46.87% | 53.822M 37.57% |
| EBITDA Q2Q % growth | 1.184M 525.46% | 3.923M 2,941.09% | 4.564M 1,984.97% | 5.271M 611.34% | 7.144M 503.38% | 8.411M 114.40% | 9.273M 103.18% | 9.945M 88.67% | 11.093M 55.28% |
| EBIT Q2Q % growth | 1.23M 14,900.00% | 3.794M 5,297.26% | 4.433M 40,946.30% | 5.138M 1,134.50% | 7.008M 469.76% | 8.274M 118.08% | 9.133M 106.02% | 9.804M 90.81% | 10.949M 56.24% |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
279.01%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
130.32%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
334.94%
EBIT Next 5 Year
N/A
HYDREIGHT TECHNOLOGIES INC / NURS.CA Forecast FAQ
What do analysts expect the price target to be for HYDREIGHT TECHNOLOGIES INC (NURS.CA)?
6 analysts have analysed NURS.CA and the average price target is 9.95 CAD. This implies a price increase of 259.03% is expected in the next year compared to the current price of 2.77.
When does HYDREIGHT TECHNOLOGIES INC (NURS.CA) report earnings?
HYDREIGHT TECHNOLOGIES INC (NURS.CA) will report earnings on 2026-04-29.
What are the consensus estimates for HYDREIGHT TECHNOLOGIES INC (NURS.CA) next earnings?
The consensus EPS estimate for the next earnings of HYDREIGHT TECHNOLOGIES INC (NURS.CA) is 0.02 CAD and the consensus revenue estimate is 15.09M CAD.
Can you provide the consensus rating for HYDREIGHT TECHNOLOGIES INC stock?
The consensus rating for HYDREIGHT TECHNOLOGIES INC (NURS.CA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.